Cecilia L Bergeria1, Sarah H Heil2, Danielle R Davis3, Joanna M Streck3, Stacey C Sigmon3, Janice Y Bunn3, Jennifer W Tidey4, Chris A Arger3, Derek D Reed5, Thomas Gallagher3, John R Hughes3, Diann E Gaalema3, Maxine L Stitzer1, Stephen T Higgins3. 1. Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2. Departments of Psychiatry and Psychological Science, Vermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA. Electronic address: sarah.heil@uvm.edu. 3. Departments of Psychiatry and Psychological Science, Vermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA. 4. Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA. 5. Department of Applied Behavioral Science, Cofrin Logan Center for Addiction Research and Treatment, University of Kansas, Lawrence, KS, USA.
Abstract
BACKGROUND:Nicotine is the addictive component in cigarettes that maintain cigarette smoking that subsequently leads to morbidity and mortality. Methods for assessing the abuse liability of cigarettes are essential to inform new tobacco product standards. This secondary analysis evaluated the utility of one subjective effects measure, the modified Cigarette Evaluation Questionnaire (mCEQ), and one behavioral economic task, the Cigarette Purchase Task (CPT), for predicting acute relative reinforcing efficacy measured by concurrent choice Self-Administration (SA). METHODS:Smokers (N = 169) belonging to one of three vulnerable populations participated in a multi-site, double-blind study evaluating research cigarettes with varying levels of nicotine (0.4, 2.4, 5.2, 15.8 mg/g). Participants sampled cigarettes and completed the mCEQ and CPT. In subsequent sessions, cigarette preference was assessed using a concurrent choice SA procedure. Mixed-model repeated measures analysis of variance tests were used to evaluate the utility of the mCEQ subscales and CPT indices for predicting preference for the higher compared to lower nicotine content cigarettes. In addition, stepwise regressions were used to determine which subscales and indices independently predicted concurrent choice SA. RESULTS: Greater increases on the Satisfaction and Enjoyment of Respiratory Tract SensationsmCEQ subscales independently predicted higher dose preference in concurrent choice testing. Elasticity was the only CPT index that predicted choice. However, its predictive utility differed by dose among opioid-maintained individuals. CONCLUSION: The mCEQ and CPT predict behavioral measures of relative reinforcing efficacy as assessed in concurrent choice SA, with the mCEQ Satisfaction and Enjoyment of Respiratory Tract Sensations subscales being the strongest independent predictors.
RCT Entities:
BACKGROUND:Nicotine is the addictive component in cigarettes that maintain cigarette smoking that subsequently leads to morbidity and mortality. Methods for assessing the abuse liability of cigarettes are essential to inform new tobacco product standards. This secondary analysis evaluated the utility of one subjective effects measure, the modified Cigarette Evaluation Questionnaire (mCEQ), and one behavioral economic task, the Cigarette Purchase Task (CPT), for predicting acute relative reinforcing efficacy measured by concurrent choice Self-Administration (SA). METHODS: Smokers (N = 169) belonging to one of three vulnerable populations participated in a multi-site, double-blind study evaluating research cigarettes with varying levels of nicotine (0.4, 2.4, 5.2, 15.8 mg/g). Participants sampled cigarettes and completed the mCEQ and CPT. In subsequent sessions, cigarette preference was assessed using a concurrent choice SA procedure. Mixed-model repeated measures analysis of variance tests were used to evaluate the utility of the mCEQ subscales and CPT indices for predicting preference for the higher compared to lower nicotine content cigarettes. In addition, stepwise regressions were used to determine which subscales and indices independently predicted concurrent choice SA. RESULTS: Greater increases on the Satisfaction and Enjoyment of Respiratory Tract SensationsmCEQ subscales independently predicted higher dose preference in concurrent choice testing. Elasticity was the only CPT index that predicted choice. However, its predictive utility differed by dose among opioid-maintained individuals. CONCLUSION: The mCEQ and CPT predict behavioral measures of relative reinforcing efficacy as assessed in concurrent choice SA, with the mCEQ Satisfaction and Enjoyment of Respiratory Tract Sensations subscales being the strongest independent predictors.
Authors: Joseph C Cappelleri; Andrew G Bushmakin; Christine L Baker; Elizabeth Merikle; Abayomi O Olufade; David G Gilbert Journal: Addict Behav Date: 2006-07-27 Impact factor: 3.913
Authors: Stephen T Higgins; Allison N Kurti; Ryan Redner; Thomas J White; Diana R Keith; Diann E Gaalema; Brian L Sprague; Cassandra A Stanton; Megan E Roberts; Nathan J Doogan; Jeff S Priest Journal: Prev Med Date: 2016-02-21 Impact factor: 4.018
Authors: Jeffrey S Stein; A George Wilson; Mikhail N Koffarnus; Michael C Judd; Warren K Bickel Journal: Psychopharmacology (Berl) Date: 2016-10-11 Impact factor: 4.530
Authors: Tracy T Smith; Rachel N Cassidy; Jennifer W Tidey; Xianghua Luo; Chap T Le; Dorothy K Hatsukami; Eric C Donny Journal: Addiction Date: 2016-11-28 Impact factor: 6.526
Authors: Stephen T Higgins; Sarah H Heil; Stacey C Sigmon; Jennifer W Tidey; Diann E Gaalema; Maxine L Stitzer; Hanna Durand; Janice Y Bunn; Jeff S Priest; Christopher A Arger; Mollie E Miller; Cecilia L Bergeria; Danielle R Davis; Joanna M Streck; Ivori Zvorsky; Ryan Redner; Ryan Vandrey; Lauren R Pacek Journal: Psychopharmacology (Berl) Date: 2016-10-06 Impact factor: 4.530
Authors: Mari S Gades; Ashley Petersen; Ellen Meier; Bruce R Lindgren; Richard J O'Connor; Peter G Shields; Dorothy Hatsukami Journal: Drug Alcohol Depend Date: 2020-04-25 Impact factor: 4.492
Authors: Neil B Varshneya; Kelly E Dunn; Caitlyn J Grubb; Sandra I Okobi; Andrew S Huhn; Cecilia L Bergeria Journal: Exp Clin Psychopharmacol Date: 2022-03-10 Impact factor: 3.492
Authors: Cecilia L Bergeria; Sean B Dolan; Matthew W Johnson; Claudia M Campbell; Kelly E Dunn Journal: J Psychopharmacol Date: 2020-04-08 Impact factor: 4.153
Authors: Tracy T Smith; Eric C Donny; Xianghua Luo; Alicia M Allen; Dana M Carroll; Rachel L Denlinger-Apte; Sarah S Dermody; Joseph S Koopmeiners; F Joseph McClernon; Lauren R Pacek; Ryan Vandrey; Dorothy K Hatsukami Journal: Nicotine Tob Res Date: 2019-12-23 Impact factor: 4.244